Which antidepressants are safe to prescribe for a patient on amiodarone therapy?

Safe Antidepressants in Patients on Amiodarone

For patients on amiodarone therapy, SSRIs (selective serotonin reuptake inhibitors) such as sertraline, citalopram, escitalopram, and the atypical antidepressant mirtazapine are the safest choices, while tricyclic antidepressants and trazodone should be avoided due to significant QT prolongation risk.

Key Drug Interaction Concerns

The primary safety concern when combining antidepressants with amiodarone is additive QT prolongation, which increases the risk of torsades de pointes—a potentially fatal ventricular arrhythmia. Amiodarone is a potent CYP3A4 and CYP2D6 inhibitor 1, which can increase plasma levels of antidepressants metabolized through these pathways.

Recommended Antidepressants

First-Line Choices (Safest):

• SSRIs: Sertraline, citalopram (low doses ≤20 mg), escitalopram (≤10 mg), and paroxetine

  • These have minimal to moderate QT effects at therapeutic doses
  • Sertraline has the most favorable cardiac safety profile among SSRIs 2

• Mirtazapine: An atypical antidepressant with minimal cardiac effects

  • Does not significantly prolong QT interval
  • Not a major CYP3A4 substrate

• Bupropion: Generally safe from a cardiac standpoint

  • No significant QT prolongation
  • May increase blood pressure—monitor accordingly

Antidepressants to AVOID

Absolutely Contraindicated:

• Tricyclic antidepressants (TCAs): Amitriptyline, imipramine, desipramine, nortriptyline

  • Cause significant QT prolongation and conduction abnormalities 3
  • Sodium channel blocking effects compound amiodarone's cardiac effects
  • Historical data shows TCAs are "second only to analgesics as a cause of serious overdose toxicity" with cardiac manifestations including PR and QRS prolongation 3

• Trazodone:

  • Case reports document QT prolongation and torsades de pointes when combined with amiodarone 1, 4
  • A 1995 case report specifically described marked QT prolongation and polymorphous ventricular tachycardia when trazodone was added to previously well-tolerated amiodarone therapy 4
  • FDA labeling explicitly warns about this interaction 1

Use with Extreme Caution (Requires Monitoring):

• Citalopram and escitalopram at higher doses:
  • FDA has dose restrictions due to QT prolongation (citalopram >20 mg/day, escitalopram >10 mg/day in patients with cardiac risk factors)
  • If used with amiodarone, stay at lowest effective doses

Clinical Management Algorithm

Before Initiating Antidepressant Therapy:

1. Obtain baseline ECG to measure QTc interval

   • If QTc >500 ms, avoid any QT-prolonging antidepressant
   • If QTc 480-500 ms, proceed with extreme caution using only SSRIs with minimal QT effects

2. Check electrolytes: Correct hypokalemia and hypomagnesemia before starting therapy 5

3. Review all medications for additional QT-prolonging drugs (see www.crediblemeds.org)

During Treatment:

1. Start at lowest effective dose and titrate slowly

2. Repeat ECG 1-2 weeks after starting antidepressant and after any dose increase

   • Discontinue if QTc increases >60 ms from baseline or exceeds 500 ms 5

3. Monitor for bradycardia as amiodarone can cause sinus node dysfunction, which increases torsades risk 5

4. Avoid other QT-prolonging medications: Including macrolide antibiotics, fluoroquinolones, and antipsychotics 1

Important Caveats

• Amiodarone has a very long half-life (weeks to months), so drug interactions persist long after discontinuation 1, 6

• Female sex, advanced age, heart failure, and structural heart disease all increase the risk of drug-induced torsades de pointes 5

• Diuretic therapy commonly used in cardiac patients can cause electrolyte abnormalities that further increase arrhythmia risk 5

• The 2006 ACC/AHA/ESC guidelines note that while tricyclic antidepressants block sodium channels like Class I antiarrhythmics, "the extent to which this prohibition on sodium channel blockers in patients with structural heart disease extends to tricyclic antidepressants...is unknown" 3—however, given safer alternatives exist, this uncertainty argues for avoiding TCAs entirely

Bottom Line

Choose sertraline, mirtazapine, or bupropion as first-line agents. Obtain baseline and follow-up ECGs. Never use trazodone or tricyclic antidepressants with amiodarone. If depression is severe and refractory, psychiatric consultation is warranted to weigh risks versus benefits of alternative strategies.